Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...
WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
NHS Blood and Transplant's Therapeutic Apheresis Services (TAS) and Cellular and Molecular Therapies (CMT) teams are ...
Cash balance of $116 million as of June 30, 2026 expected to fund operations through the end of 2028, supporting anticipated ...
Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization ...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...
Denifanstat showed continued improvement and sustained efficacy across all efficacy endpoints through 52 weeks, including 57% ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...
About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results